References for “Revisiting the CATIE schizophrenia study”
Carpenter WT, et al. “Lessons to Take Home from CATIE,” Psychiatric Services (May 2008): Vol. 59, No. 5, pp. 523-25.
Jones PB, et al. “Randomized Controlled Trial of the Effect on Quality of Life of Second- Versus First-Generation Antipsychotic Drugs in Schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1),” Archives of General Psychiatry (Oct. 2006): Vol. 63, No. 10, pp. 1079–87.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.